-
1
-
-
0037431022
-
An association between atherosclerosis and venous thrombosis
-
Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, Prins MH, Girolami A. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003; 348: 1435-1441
-
(2003)
N Engl J Med.
, vol.348
, pp. 1435-1441
-
-
Prandoni, P.1
Bilora, F.2
Marchiori, A.3
Bernardi, E.4
Petrobelli, F.5
Lensing, A.W.6
Prins, M.H.7
Girolami, A.8
-
2
-
-
0030970663
-
Activated protein C resistance, factor V Leiden and peripheral vascular disease
-
Foley PW, Irvine CD, Standen GR et al. Activated protein C resistance, factor V Leiden and peripheral vascular disease. Cardiovasc Surg 1997; 5: 157-160
-
(1997)
Cardiovasc Surg
, vol.5
, pp. 157-160
-
-
Foley, P.W.1
Irvine, C.D.2
Standen, G.R.3
-
3
-
-
0032783974
-
Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients
-
Gaustadnes M, Rudiger N, Moller J, Rasmussen K, Bjerregaard Larsen T, Ingerslev J. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients. Blood Coagul Fibrinolysis 1999; 10: 251-259
-
(1999)
Blood Coagul Fibrinolysis
, vol.10
, pp. 251-259
-
-
Gaustadnes, M.1
Rudiger, N.2
Moller, J.3
Rasmussen, K.4
Bjerregaard Larsen, T.5
Ingerslev, J.6
-
4
-
-
0002695076
-
Hereditary and acquired thrombophilic syndromes
-
Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds). Philadelphia: Lippincott Williams & Wilkins, Foley PW, 1997
-
Marder VJ, Matei DE. Hereditary and acquired thrombophilic syndromes. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds). Hemostasis and thrombosis: basic principles & clinical practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2000 (Foley PW, 1997): 1243-1276
-
(2000)
Hemostasis and Thrombosis: Basic Principles & Clinical Practice. 4th Ed.
, pp. 1243-1276
-
-
Marder, V.J.1
Matei, D.E.2
-
5
-
-
0002877029
-
Thrombosis and atherosclerosis
-
Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds). Philadelphia: Lippincott Williams & Wilkins
-
Libby P, Simon DI. Thrombosis and atherosclerosis. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds). Hemostasis and thrombosis: basic principles & clinical practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 743-752
-
(2000)
Hemostasis and Thrombosis: Basic Principles & Clinical Practice. 4th Ed.
, pp. 743-752
-
-
Libby, P.1
Simon, D.I.2
-
6
-
-
0033669156
-
Multiple mechanisms of thrombosis complicating atherosclerotic plaques
-
Libby P. Multiple mechanisms of thrombosis complicating atherosclerotic plaques. Clin Cardiol 2000; 23 (Suppl 6): VI-3
-
(2000)
Clin Cardiol
, vol.23
, Issue.6 SUPPL.
-
-
Libby, P.1
-
7
-
-
0031848603
-
Atherosclerosis: Coagulation and fibrinolysis
-
Sueishi K, Ichikawa K, Kato K, Nakagawa K, Chen YX. Atherosclerosis: coagulation and fibrinolysis. Semin Thromb Hemost 1998; 24: 255-260
-
(1998)
Semin Thromb Hemost
, vol.24
, pp. 255-260
-
-
Sueishi, K.1
Ichikawa, K.2
Kato, K.3
Nakagawa, K.4
Chen, Y.X.5
-
8
-
-
0030730606
-
Thrombosis and atherosclerosis
-
Holvoet P, Collen D. Thrombosis and atherosclerosis. Curr Opin Lipidol 1997; 8: 320-328
-
(1997)
Curr Opin Lipidol
, vol.8
, pp. 320-328
-
-
Holvoet, P.1
Collen, D.2
-
9
-
-
0030839065
-
Markers of platelet activation and oxidant stress in atherothrombotic disease
-
FitzGerald GA, Tigges J, Barry P, Lawson JA. Markers of platelet activation and oxidant stress in atherothrombotic disease. Thromb Haemost 1997; 78: 280-284
-
(1997)
Thromb Haemost
, vol.78
, pp. 280-284
-
-
Fitzgerald, G.A.1
Tigges, J.2
Barry, P.3
Lawson, J.A.4
-
10
-
-
0031782039
-
Participation des mécanismes de la thrombose et de l'hémostase aux étapes initiales de l'athérosclérose
-
Drouet L, Mazoyer E, Bal dit Sollier C, Hainaud P, Ripoll L. Participation des mécanismes de la thrombose et de l'hémostase aux étapes initiales de l'athérosclérose. Arch Mal Coeur Vaiss 1998; 91: 41-51
-
(1998)
Arch Mal Coeur Vaiss
, vol.91
, pp. 41-51
-
-
Drouet, L.1
Mazoyer, E.2
Bal Dit Sollier, C.3
Hainaud, P.4
Ripoll, L.5
-
11
-
-
0035726359
-
Plasma fibrin D-dimer levels and risk of stable coronary artery disease: Results of a large case-control study
-
Koenig W, Rothenbacher D, Hoffmeister A, Griesshammer M, Brenner H. Plasma fibrin D-dimer levels and risk of stable coronary artery disease: results of a large case-control study. Arterioscler Thromb Vasc Biol 2001; 21: 1701-1705
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 1701-1705
-
-
Koenig, W.1
Rothenbacher, D.2
Hoffmeister, A.3
Griesshammer, M.4
Brenner, H.5
-
12
-
-
0036851876
-
Platelets in atherothrombosis
-
Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-1234
-
(2002)
Nat Med
, vol.8
, pp. 1227-1234
-
-
Ruggeri, Z.M.1
-
13
-
-
0030801420
-
Platelet-leukocyte-endothelial cell interaction on the blood vessel wall
-
Celi A, Lorenzet R, Furie B, Furie BC. Platelet-leukocyte-endothelial cell interaction on the blood vessel wall. Semin Hematol 1997; 34: 327-335
-
(1997)
Semin Hematol
, vol.34
, pp. 327-335
-
-
Celi, A.1
Lorenzet, R.2
Furie, B.3
Furie, B.C.4
-
14
-
-
0034680348
-
P-selectin expression on platelets determines size and stability of platelet aggregates
-
Merten M, Thiagarajan P. P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 2000; 102: 1931-1936
-
(2000)
Circulation
, vol.102
, pp. 1931-1936
-
-
Merten, M.1
Thiagarajan, P.2
-
15
-
-
0034655567
-
Pulmonary Embolism Prevention trial Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
-
Pulmonary Embolism Prevention trial Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355: 1295-1302
-
(2000)
Lancet
, vol.355
, pp. 1295-1302
-
-
-
16
-
-
0027942293
-
Antiplatelet therapy for thromboprophylaxis: The need for careful consideration of the evidence from randomised trials
-
Antiplatelet Trialists' Collaboration
-
Collins R, Baigent C, Sandercock P, Peto R. Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration. BMJ 1994; 309: 1215-1217
-
(1994)
BMJ
, vol.309
, pp. 1215-1217
-
-
Collins, R.1
Baigent, C.2
Sandercock, P.3
Peto, R.4
-
17
-
-
0028217263
-
Collaborative overview of randomised trials of antiplatelet therapy -III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients
-
Antiplatelet Trialists' Collaboration
-
Collaborative overview of randomised trials of antiplatelet therapy -III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ 1994; 308: 235-246
-
(1994)
BMJ
, vol.308
, pp. 235-246
-
-
-
18
-
-
0029978487
-
Venous thromboembolism during pregnancy
-
Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996; 335: 108-114
-
(1996)
N Engl J Med
, vol.335
, pp. 108-114
-
-
Toglia, M.R.1
Weg, J.G.2
-
19
-
-
0033541493
-
Thrombosis in pregnancy: Maternal and fetal issues
-
Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353: 1158-1165
-
(1999)
Lancet
, vol.353
, pp. 1158-1165
-
-
Greer, I.A.1
-
20
-
-
0032741802
-
Risk factors for venous thrombotic disease
-
Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999; 82: 610-619
-
(1999)
Thromb Haemost
, vol.82
, pp. 610-619
-
-
Rosendaal, F.R.1
-
21
-
-
0242585716
-
Blood coagulation
-
Dahlback B. Blood coagulation. Lancet 2000; 355: 1627-1632
-
(2000)
Lancet
, vol.355
, pp. 1627-1632
-
-
Dahlback, B.1
-
22
-
-
23444433484
-
Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry
-
Dardenne M, de Moraes M, Kelly PA, Gagnerault MC. Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry. Endocrinology 1994; 134: 2018-2114
-
(1994)
Endocrinology
, vol.134
, pp. 2018-2114
-
-
Dardenne, M.1
De Moraes, M.2
Kelly, P.A.3
Gagnerault, M.C.4
-
23
-
-
0025097880
-
Measurement of platelet activation by fluorescence-activated flowcytometry
-
Corash L. Measurement of platelet activation by fluorescence-activated flowcytometry. Blood Cells 1990; 16: 97-106
-
(1990)
Blood Cells
, vol.16
, pp. 97-106
-
-
Corash, L.1
-
24
-
-
0035217821
-
PRL as a novel potent cofactor for platelet aggregation
-
Wallaschofski H, Donne M, Eigenthaler M, Hentschel B, Faber R, Stepan H, Koksch M, Lohmann T. PRL as a novel potent cofactor for platelet aggregation. J Clin Endocrinol Metab 2001; 86: 5912-5919
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 5912-5919
-
-
Wallaschofski, H.1
Donne, M.2
Eigenthaler, M.3
Hentschel, B.4
Faber, R.5
Stepan, H.6
Koksch, M.7
Lohmann, T.8
-
25
-
-
0034619072
-
Antipsychotic drug use and risk of first-time idiopathic venous thrombembolism: A case-control study
-
Zornberg GI, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thrombembolism: a case-control study. Lancet 1999; 356: 1219-1223
-
(1999)
Lancet
, vol.356
, pp. 1219-1223
-
-
Zornberg, G.I.1
Jick, H.2
-
26
-
-
1442339751
-
-
In press
-
Wallaschofski H, Eigenthaler M, Kiefer M, Manfred D, Hentschel B, Gertz HJ, Lohmann T. Hyperprolactinemia in patients on antipsychotic drugs causes ADP stimulated platelet activation that might explain the increased risk for venous thromboembolism. In press
-
Hyperprolactinemia in Patients on Antipsychotic Drugs Causes ADP Stimulated Platelet Activation that Might Explain the Increased Risk for Venous Thromboembolism
-
-
Wallaschofski, H.1
Eigenthaler, M.2
Kiefer, M.3
Manfred, D.4
Hentschel, B.5
Gertz, H.J.6
Lohmann, T.7
-
27
-
-
0037561520
-
Prolactin Receptor Signaling during Platelet Activation
-
Wallaschofski H, Kobsar A, Siegemund A, Sokolova O, Hentschel B, Tuschy U, Lohmann T, Eigenthaler M. Prolactin Receptor Signaling during Platelet Activation. M Horm Metab Res. 2003; 35: 228-235
-
(2003)
M Horm Metab Res.
, vol.35
, pp. 228-235
-
-
Wallaschofski, H.1
Kobsar, A.2
Siegemund, A.3
Sokolova, O.4
Hentschel, B.5
Tuschy, U.6
Lohmann, T.7
Eigenthaler, M.8
-
28
-
-
0032971218
-
Leptin promotes aggregation of human platelets via the long form of its receptor
-
Nakata M, Yada T, Soejima N, Maruyama I. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 1999; 48: 426-429
-
(1999)
Diabetes
, vol.48
, pp. 426-429
-
-
Nakata, M.1
Yada, T.2
Soejima, N.3
Maruyama, I.4
-
29
-
-
0035179087
-
Leptin-dependent platelet aggregation and arterial thrombosis suggest a mechanism for atherothrombotic disease in obesity
-
Konstantinidis S, Schäfer K, Koschnick S, Loskutoff DJ. Leptin-dependent platelet aggregation and arterial thrombosis suggest a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001; 108: 1533-1540
-
(2001)
J Clin Invest
, vol.108
, pp. 1533-1540
-
-
Konstantinidis, S.1
Schäfer, K.2
Koschnick, S.3
Loskutoff, D.J.4
-
30
-
-
0034122291
-
Effect of leptin in platelet and endothelial cells. Obesity and arterial thrombosis
-
Maruyama I, Nakata M, Yamaji K. Effect of leptin in platelet and endothelial cells. Obesity and arterial thrombosis. Ann N Y Acad Sci 2000; 902: 315-319
-
(2000)
Ann N Y Acad Sci
, vol.902
, pp. 315-319
-
-
Maruyama, I.1
Nakata, M.2
Yamaji, K.3
-
32
-
-
0035684130
-
The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity
-
Konstantinides S, Schafer K, Loskutoff DJ. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. Ann N Y Acad Sci Dec 2001; 947: 134-141; discussion 141-142
-
(2001)
Ann N Y Acad Sci Dec
, vol.947
, pp. 134-141
-
-
Konstantinides, S.1
Schafer, K.2
Loskutoff, D.J.3
-
33
-
-
0035490834
-
Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency
-
Ozata M, Aveu F, Durmus O, Yilmaz I, Ozdemir IC, Yalcin A. Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency. Obesity Research 2001; 9: 627-630
-
(2001)
Obesity Research
, vol.9
, pp. 627-630
-
-
Ozata, M.1
Aveu, F.2
Durmus, O.3
Yilmaz, I.4
Ozdemir, I.C.5
Yalcin, A.6
-
34
-
-
0037012483
-
Effect of leptin on arterial thrombosis following vascular injury in mice
-
Bodary PF, Westrick RJ, Wickenheiser KJ, Shen Y, Eitzman DT. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 2002; 287: 1706-1709
-
(2002)
JAMA
, vol.287
, pp. 1706-1709
-
-
Bodary, P.F.1
Westrick, R.J.2
Wickenheiser, K.J.3
Shen, Y.4
Eitzman, D.T.5
-
35
-
-
1442266276
-
Leptin linked to blood clots in obesity
-
Pirisi A. Leptin linked to blood clots in obesity. Lancet 2002; 359: 1215
-
(2002)
Lancet
, vol.359
, pp. 1215
-
-
Pirisi, A.1
-
36
-
-
1442290716
-
-
Submitted
-
Wallaschofski H, Kobsar A, Sokolova O, Stepan H, Faber R, Siegemund A, Eigenthaler M, Lohmann T. Differences in platelet activation by prolactin and leptin. Submitted
-
Differences in Platelet Activation by Prolactin and Leptin
-
-
Wallaschofski, H.1
Kobsar, A.2
Sokolova, O.3
Stepan, H.4
Faber, R.5
Siegemund, A.6
Eigenthaler, M.7
Lohmann, T.8
-
37
-
-
0031800686
-
Increased body weight associated with prolactin secreting pituitary adenomas: Weight loss with normalization of prolactin levels
-
Oxf
-
Greenman Y, Tordjman K, Stern N. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clin Endocrinol (Oxf) 1998; 48: 547-553
-
(1998)
Clin Endocrinol
, vol.48
, pp. 547-553
-
-
Greenman, Y.1
Tordjman, K.2
Stern, N.3
-
38
-
-
13344295079
-
Serum immunoreactive-leptin concentrations in normal-weight and obese humans
-
Considine RV, Sinha MK, Heiman ML, Kriaciunas A, Stephens TW, Nyce MR, Ohanessian JP, Marco CC, McKee LJ, Bauer TR, Caro TR. Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl. J Med 1996; 334: 292-295
-
(1996)
N Engl J Med
, vol.334
, pp. 292-295
-
-
Considine, R.V.1
Sinha, M.K.2
Heiman, M.L.3
Kriaciunas, A.4
Stephens, T.W.5
Nyce, M.R.6
Ohanessian, J.P.7
Marco, C.C.8
McKee, L.J.9
Bauer, T.R.10
Caro, T.R.11
-
39
-
-
0028845877
-
Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
-
Maffei M et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-1161
-
(1995)
Nat Med
, vol.1
, pp. 1155-1161
-
-
Maffei, M.1
-
40
-
-
0032558725
-
Leptin and the regulation of body weight in mammals
-
Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770
-
(1998)
Nature
, vol.395
, pp. 763-770
-
-
Friedman, J.M.1
Halaas, J.L.2
-
42
-
-
0001820949
-
Role of leptin in pregnancy, a review
-
Sagawa N, Yura S, Itoh H, Mise H, Kakui K, Korita D, Takemura M, Nuamah MA, Ogawa Y, Masuzaki H, Nakao K, Fujii S. Role of leptin in pregnancy, a review. Placenta 2002; 23 (Suppl A): S80-86
-
(2002)
Placenta
, vol.23
, Issue.SUPPL. A
-
-
Sagawa, N.1
Yura, S.2
Itoh, H.3
Mise, H.4
Kakui, K.5
Korita, D.6
Takemura, M.7
Ma, N.8
Ogawa, Y.9
Masuzaki, H.10
Nakao, K.11
Fujii, S.12
-
43
-
-
0033794850
-
Human leptin: From an adipocyte hormone to an endocrine mediator
-
Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000; 143: 293-311
-
(2000)
Eur J Endocrinol
, vol.143
, pp. 293-311
-
-
Wauters, M.1
Considine, R.V.2
Van Gaal, L.F.3
-
44
-
-
0037338178
-
Antipsychotic-induced hyperprolactinaemia in women: Pathophysiology, severity and consequences. Selective literature review
-
Wieck A, Haddad PM. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry 2003; 182: 199-204
-
(2003)
Br J Psychiatry
, vol.182
, pp. 199-204
-
-
Wieck, A.1
Haddad, P.M.2
-
45
-
-
0034930903
-
Effects of long-term treatment with antipsychotics on serum leptin levels
-
Herran A, Garcia-Unzueta MT, Amado JA, de La Maza MT, Alvarez C, Vazquez-Barquero JL. Effects of long-term treatment with antipsychotics on serum leptin levels. Br J Psychiatry 2001; 179: 59-62
-
(2001)
Br J Psychiatry
, vol.179
, pp. 59-62
-
-
Herran, A.1
Garcia-Unzueta, M.T.2
Amado, J.A.3
De La Maza, M.T.4
Alvarez, C.5
Vazquez-Barquero, J.L.6
-
46
-
-
0033552883
-
Atherosclerosis - An inflammatory disease
-
Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126
-
(1999)
N Engl J Med
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
47
-
-
0033782028
-
Leptin in the regulation of immunity, inflammation, and hematopoiesis
-
Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000; 68: 437-446
-
(2000)
J Leukoc Biol
, vol.68
, pp. 437-446
-
-
Fantuzzi, G.1
Faggioni, R.2
-
48
-
-
17944381122
-
Overview: Prolactin and autoimmunity
-
Walker SE, Yu-Lee L-Y. Overview: prolactin and autoimmunity. Lupus 2001; 10: 669
-
(2001)
Lupus
, vol.10
, pp. 669
-
-
Walker, S.E.1
Yu-Lee, L.-Y.2
-
50
-
-
0344959452
-
Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort
-
Soderberg S, Ahren B, Stegmayr B, Johnson O, Wiklund PG, Weinehall L, Hallmans G, Olsson T. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke 1999; 30: 328-337
-
(1999)
Stroke
, vol.30
, pp. 328-337
-
-
Soderberg, S.1
Ahren, B.2
Stegmayr, B.3
Johnson, O.4
Wiklund, P.G.5
Weinehall, L.6
Hallmans, G.7
Olsson, T.8
|